Raltegravir (generic for Isentress) is used for HIV post-exposure prophylaxis. The decision to start post-exposure prophylaxis after a possible exposure to HIV is complex, and the standard of care is to initiate post-exposure prophylaxis medication only after laboratory testing. Seeking immediate medical attention is the best option. However, in an emergency or disaster situation in which medical care is unavailable, take this medication, along with emtricitabine/tenofovir, as soon as possible (and within 72 hours) to prevent infection if you believe you have suffered a major exposure to HIV. Immediately seek qualified medical care.
Do not take to prevent infections other than HIV. Do not take as pre-exposure prophylaxis.
Do not stop taking this medication once you start without consulting a medical provider.
|HIV post-exposure prophylaxis||emtricitabine 200 mg by mouth once a day PLUS tenofovir 300 mg by mouth once a day PLUS raltegravir 400 mg by mouth twice a day|
The overview provided here is for general information only and does not include all the information needed to use this item safely and effectively. See full prescribing information for further detail.
Pharmacy and Medications
Who can Buy
Buying a Bag
Inside the Bag
Join our mailing list
The information provided on this site is intended for your general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. You should not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition.
If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.